Published in Clin Cosmet Investig Dermatol on May 07, 2012
The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol (2005) 6.27
Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology (1997) 3.48
Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem (1997) 2.53
Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol (1991) 2.52
Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol (2008) 2.16
Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol (2002) 1.94
Patients with psoriasis and their compliance with medication. J Am Acad Dermatol (1999) 1.28
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28
Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy (2010) 1.19
Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostasis. J Invest Dermatol (2006) 1.07
Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis. J Drugs Dermatol (2011) 1.00
A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol (2001) 0.95
Patients' vehicle preference for corticosteroid treatments of scalp psoriasis. Am J Clin Dermatol (2003) 0.95
Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology (2005) 0.93
A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol (2007) 0.93
The prevalence of common skin conditions in Australian school students: 2. Atopic dermatitis. Br J Dermatol (1999) 0.92
Black box warning for topical calcineurin inhibitors and the death of common sense. Dermatol Online J (2006) 0.92
The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy. Drug Saf (2008) 0.92
Therapeutic moisturizers. Dermatol Clin (2000) 0.90
Skin-sensitizing and irritant properties of propylene glycol. Contact Dermatitis (2005) 0.89
Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br J Dermatol (2005) 0.86
Estimating the impact on the food chain of changing bovine spongiform encephalopathy (BSE) control measures: the BSE control model. Prev Vet Med (2010) 0.86
On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides. J Dermatol Sci (2008) 0.85
Ceramide modulates HERG potassium channel gating by translocation into lipid rafts. Am J Physiol Cell Physiol (2010) 0.83
The influence of a cream containing 20% glycerin and its vehicle on skin barrier properties. Int J Cosmet Sci (2001) 0.82
Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons. Br J Dermatol (2008) 0.82
Dry skin and skin moisturizers. Clin Dermatol (1989) 0.79
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. J Am Acad Dermatol (2004) 1.53
Insect repellents: historical perspectives and new developments. J Am Acad Dermatol (2008) 1.40
Neurothekeoma: report of a case in an infant and review of the literature. J Am Acad Dermatol (2004) 1.27
Neonatal primary cutaneous aspergillosis: case report and review of the literature. Pediatr Dermatol (2002) 1.13
Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med (2008) 1.10
Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. Am J Clin Dermatol (2013) 0.96
A novel GJB2 (connexin 26) mutation, F142L, in a patient with unusual mucocutaneous findings and deafness. J Invest Dermatol (2003) 0.90
Nonendemic pemphigus foliaceus in children. J Am Acad Dermatol (2002) 0.87
Images in clinical medicine: African tick-bite fever after a game-hunting expedition. N Engl J Med (2015) 0.86
Bacterial resistance and impetigo treatment trends: a review. Pediatr Dermatol (2012) 0.84
Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent products. J Am Acad Dermatol (2008) 0.83
Ecthyma gangrenosum and neutropenia in a previously healthy child. Pediatr Dermatol (2012) 0.81
New and emerging trends in the treatment of atopic dermatitis. Patient Prefer Adherence (2008) 0.81
A new paradigm for calculating skin dose. Brachytherapy (2012) 0.81
Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides. J Drugs Dermatol (2013) 0.80
MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr (2008) 0.79
Primary focal hyperhidrosis: scope of the problem. Cutis (2007) 0.78
Facial hyperhidrosis: best practice recommendations and special considerations. Cutis (2007) 0.78
Management of acne vulgaris. J Pediatr Health Care (2011) 0.78
DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis. J Drugs Dermatol (2016) 0.78
Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects. J Drugs Dermatol (2008) 0.78
Evaluation of adrenal suppression of a lipid enhanced, topical emollient cream formulation of hydrocortisone butyrate 0.1% in treating children with atopic dermatitis. Pediatr Dermatol (2007) 0.76
Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol (2010) 0.76
Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults. J Dermatolog Treat (2008) 0.76
Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants. J Drugs Dermatol (2020) 0.75
Tretinoin microsphere gel 0.04% pump for treating acne vulgaris in preadolescents: a randomized, controlled study. Pediatr Dermatol (2012) 0.75
Multiple bilateral vesiculobullous lesions on the lower extremities. Arch Dermatol (2003) 0.75
Recognizing and Managing Staphylococcal Scalded Skin Syndrome in the Emergency Department. Pediatr Emerg Care (2022) 0.75
Pediatric photosensitivity disorders. Dermatol Clin (2013) 0.75
A review of beta antagonist treatment for infantile hemangioma. J Drugs Dermatol (2012) 0.75
Scrotal Buschke-Lowenstein tumor in an AIDS patient. Sex Transm Dis (2012) 0.75
Palmar and plantar hyperhidrosis: best practice recommendations and special considerations. Cutis (2007) 0.75
Skin cancer presenting as a nonhealing wound: the association of polio and skin cancer. Arch Dermatol (2007) 0.75
Skin and Wound Care in Lymphedema Patients: A Taxonomy, Primer, and Literature Review. Adv Skin Wound Care (2017) 0.75